• Explore /
  • Poster
  • / Real-world study of treatment patterns and outcomes among patients with metastatic pancreatic ductal adenocarcinoma (PDAC) in Europe.

Real-world study of treatment patterns and outcomes among patients with metastatic pancreatic ductal adenocarcinoma (PDAC) in Europe.

Abstract Poster

Authors

Julien Taieb

Julien Taieb

Georges Pompidou European Hospital, Paris, France

Julien Taieb , Pascal Hammel , Michele Reni , Daniel H. Palmer , John A. Bridgewater , Antonio Cubillo , Gerald W. Prager , Alice Vermeire , Nathalie D'Esquermes , Fabienne Biville-Hedouin , Zhaoyang Teng , Thomas Seufferlein , Teresa Macarulla

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session: Pancreatic Cancer

Track

Pancreatic Cancer

Sub Track

Patient-Reported Outcomes and Real-World Evidence

Citation

J Clin Oncol 39, 2021 (suppl 3; abstr 391)

DOI

10.1200/JCO.2021.39.3_suppl.391

Abstract #

391

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

Poster

2018 Gastrointestinal Cancers Symposium

Second-line treatment of modified FOLFIRINOX or nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma.

Second-line treatment of modified FOLFIRINOX or nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma.

First Author: Masato Ozaka

First Author: Syvart Dennen

First Author: Nai-Jung Chiang

First Author: Zev A. Wainberg